Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.
about
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcomeToward unraveling the complexity of simple epithelial keratins in human diseasePancreatic solitary and synchronous metastasis from breast cancer: a case report and systematic review of controversies in diagnosis and treatment.Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a case control study.Significance of immunohistochemistry in breast cancerDifferent gene expression patterns in invasive lobular and ductal carcinomas of the breast.Keratin expression in human tissues and neoplasms.Unique presentations of invasive lobular breast cancer: a case series.Keratins in health and cancer: more than mere epithelial cell markersGastric obstruction secondary to metastatic breast cancer: a case report and literature reviewIntegrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts.Ruptured gallbladder as the first presentation of breast cancerAppendicitis caused by the metastasis of HER2-positive breast cancer.Usefulness of traditional serum biomarkers for management of breast cancer patients.Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact.From plasminogen to plasmin: role of plasminogen receptors in human cancer.Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.Breast Cancer Metastases to the Gastrointestinal Tract Presenting with Anemia and Intra-abdominal Bleed.Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients.Invasive lobular carcinoma: to grade or not to grade.Radiographically occult intrasinusoidal liver metastases leading to hepatic failure in a case of breast cancer.Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma.Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer.
P2860
Q21092905-E98741F6-B215-40A8-B190-D1D44F10F643Q24657673-48691183-D3BF-46B0-BAE3-74A79E60D8A1Q30725747-04F60B1C-7EAF-4561-B017-1AABC80A7ACFQ33863793-A228BAE1-729A-4517-9B4B-7A0AF8CF14D8Q34023682-BE1FFC52-92BD-4021-9A28-0B451A40ED73Q34358592-FD7A5969-6291-48F6-85CA-5012F17DBA59Q34636832-EC1455FE-11EE-42A6-BC57-9C211F738F60Q34903325-7F8538F4-4803-4CF1-BCC8-9F765D07E831Q35161934-4DBC521C-195E-4EB0-BDAA-F61B30036E1CQ36175779-EF60E3E5-D65C-42AD-8DEE-05830B0FF06BQ36604140-6D4E0A12-04CB-4A4F-AD4E-141B5CB2D760Q37222073-337C1AFC-BD62-4E9E-A258-3135FBD54110Q37293067-98DA8AD6-EE0C-4CB1-BBB7-CFD3B330D068Q37375636-8B86D03E-4F0C-4131-B131-9DBAB02275ECQ37414366-83A2CC41-F0C7-4489-B104-B19D64E596CBQ38269342-5E0101E2-F943-4E3B-A361-8F3C14C051ECQ38944306-EA934DDA-D3CC-433B-BF7B-2E434EDA9AA4Q40061357-14496E8C-F9E2-4253-ADE8-9DCFE70F14A6Q41635791-676551D0-B152-433F-86F8-E2201367E34CQ44234056-46C041E1-4891-407A-A649-CA667CB7E655Q45191001-126369F6-E733-44DE-A2F0-B8ADC76468C2Q50316022-2422B5E8-367B-4E82-81BF-62E7D9726CE1Q53040493-41AB9BC8-9557-4C26-8558-F088E8D719FAQ55669238-FD367171-D7F6-4064-A308-AC9D96742311
P2860
Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Cytokeratin 8 immunostaining p ...... from ductal breast carcinoma.
@en
Cytokeratin 8 immunostaining p ...... from ductal breast carcinoma.
@nl
type
label
Cytokeratin 8 immunostaining p ...... from ductal breast carcinoma.
@en
Cytokeratin 8 immunostaining p ...... from ductal breast carcinoma.
@nl
prefLabel
Cytokeratin 8 immunostaining p ...... from ductal breast carcinoma.
@en
Cytokeratin 8 immunostaining p ...... from ductal breast carcinoma.
@nl
P2093
P1476
Cytokeratin 8 immunostaining p ...... from ductal breast carcinoma.
@en
P2093
P304
P356
10.1309/CPUX-KWEH-7B26-YE19
P407
P577
2000-08-01T00:00:00Z